IRS - Sygehus Lillebælt, Forskningsenhed for Organ- og plastikkirurgi (Vejle)

Medicin og biovidenskab

1. Mammaplasty 100%
2. Perforator Flap 57%
3. Breast 52%
4. Colorectal Neoplasms 48%
5. Nipples 35%
6. Rectal Neoplasms 32%
7. Mastectomy 30%
8. Acellular Dermis 27%
9. Surgical Flaps 27%
10. Lymphoscintigraphy 26%
11. Arteries 26%
12. Colonic Neoplasms 22%
13. Superficial Back Muscles 21%
14. Neoplasms 20%
15. Mouth Neoplasms 19%
16. Male Breast Neoplasms 19%
17. Sentinel Lymph Node 18%
18. Anus Neoplasms 18%
19. Groin 18%
20. Lymph Node Excision 17%
21. Breast Neoplasms 17%
22. Early Detection of Cancer 17%
23. Anastomotic Leak 16%
24. Randomized Controlled Trials 16%
25. Morbidity 15%
26. Inguinal Hernia 15%
27. Denmark 14%
28. Seroma 14%
29. Radiotherapy 14%
30. Doppler Color Ultrasonography 13%
31. Back 13%
32. Sentinel Lymph Node Biopsy 13%
33. Mortality 13%
34. Magnetic Resonance Imaging 12%
35. Esthetics 12%
36. Herniorrhaphy 12%
37. Patient Satisfaction 12%
38. Evoked Potentials 12%
39. Colectomy 11%
40. Colorectal Surgery 11%
41. Squamous Cell Carcinoma of Head and Neck 11%
42. Mouth 11%
43. Cohort Studies 10%
44. Prospective Studies 10%
45. Shoulder 10%
46. Necrosis 10%
47. Microdialysis 10%
48. Databases 9%
49. Chemoradiotherapy 9%
50. Squamous Cell Carcinoma 9%
51. Multicenter Studies 9%
52. Reconstructive Surgical Procedures 9%
53. Radioisotopes 9%
54. Tomography 9%
55. Head and Neck Neoplasms 9%
56. Anal Canal 8%
57. Endoscopy 8%
58. Colonoscopy 8%
59. Biopsy 8%
60. Incidence 8%
61. Lipodystrophy, Partial, Acquired 8%
62. Neck Dissection 8%
63. Pain 8%
64. Fats 8%
65. Practice Guidelines 8%
66. Recurrence 8%
67. Diverticulum 8%
68. Tissue Donors 8%
69. Survival 7%
70. Chronic Pain 7%
71. Skin 7%
72. Confidence Intervals 7%
73. Stents 7%
74. Extracellular Matrix 7%
75. Neoplasm Micrometastasis 7%
76. Segmental Mastectomy 7%
77. Small Intestine 7%
78. Occult Blood 7%
79. Systematic Reviews 7%
80. Quality of Life 6%
81. Subcutaneous Fat 6%
82. Meta-Analysis 6%
83. Sigmoid Neoplasms 6%
84. Therapeutics 6%
85. Neoplasm Metastasis 6%
86. Lymph Nodes 6%
87. Penile Induration 6%
88. Immunohistochemistry 6%
89. Breast Carcinoma In Situ 6%
90. Neck 6%
91. Joints 6%
92. Dissection 6%
93. Hematoma 6%
94. Urokinase Plasminogen Activator Receptors 6%
95. Laparotomy 6%
96. Hernia 6%
97. Biomarkers 6%
98. Comorbidity 6%
99. Hyperemia 6%
100. Negative-Pressure Wound Therapy 6%